DOAC Discharge Prescription Safety

PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.

2 posts / 0 new

Last post

Fri, 05/28/2021 - 14:23

Ian Orensky

Offline

Last seen: 3 years 5 months ago

Joined: 01/27/2021 - 13:15

DOAC Discharge Prescription Safety

Good afternoon.
Has anyone had success with EMR build/decision support that improves safety of DOACs (e.g apaxaban, rivaroxaban) as the inpatient orders are converted to discharge prescriptions? A specific scenario I am concerned about is when inpatient orders are entered for apixaban 10mg BID x 7 days followed by 5mg BID, then on discharge the provider inadvertently orders 10mg BID to be continued indefinitely as a discharge prescription rather than the 5mg BID maintenance dose. Does anyone have BPAs that alert a pharmacist or provider? In-basket messages for pharmacist monitoring? Other thoughts?
Thanks.

Members Log In